Technical Analysis for GRTS - Gritstone Oncology, Inc.

Grade Last Price % Change Price Change
B 11.52 7.56% 0.81
GRTS closed up 7.56 percent on Tuesday, December 7, 2021, on 1.42 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical GRTS trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Fell Below 20 DMA Bearish 7.56%
MACD Bearish Signal Line Cross Bearish 7.56%
50 DMA Support Bullish 7.56%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 7.56%
20 DMA Support Bullish -0.52%
Upper Bollinger Band Walk Strength -0.52%
Outside Day Range Expansion -0.52%
Upper Bollinger Band Touch Strength -0.52%
Calm After Storm Range Contraction -5.65%
Older End-of-Day Signals for GRTS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% about 13 hours ago
Up 1 ATR about 13 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 14 hours ago
Rose Above Previous Day's High about 14 hours ago
60 Minute Opening Range Breakout about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGE™, which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient’s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients’ TSNA to drive the patient’s immune system to attack and destroy tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immune System Immunotherapy Oncology Cancer Immunotherapy Virotherapy Machine Learning Immunotherapies Tumors Biopsy Tumor Cell Active Immunotherapy

Is GRTS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.03
52 Week Low 2.9
Average Volume 1,110,566
200-Day Moving Average 10.00
50-Day Moving Average 10.52
20-Day Moving Average 11.22
10-Day Moving Average 11.39
Average True Range 1.17
ADX 17.49
+DI 25.24
-DI 16.47
Chandelier Exit (Long, 3 ATRs) 10.64
Chandelier Exit (Short, 3 ATRs) 13.10
Upper Bollinger Bands 12.54
Lower Bollinger Band 9.91
Percent B (%b) 0.61
BandWidth 23.40
MACD Line 0.26
MACD Signal Line 0.27
MACD Histogram -0.0074
Fundamentals Value
Market Cap 435.04 Million
Num Shares 37.8 Million
EPS -3.21
Price-to-Earnings (P/E) Ratio -3.59
Price-to-Sales 33.81
Price-to-Book 1.72
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.97
Resistance 3 (R3) 14.00 13.22 13.56
Resistance 2 (R2) 13.22 12.60 13.21 13.42
Resistance 1 (R1) 12.37 12.21 12.80 12.34 13.29
Pivot Point 11.59 11.59 11.80 11.57 11.59
Support 1 (S1) 10.74 10.97 11.17 10.70 9.75
Support 2 (S2) 9.96 10.58 9.94 9.62
Support 3 (S3) 9.11 9.96 9.48
Support 4 (S4) 9.07